Treace Medical Concepts, Inc.
Mark Gonzales has a diverse work experience spanning over 17 years. Mark began their career as an Assistant Vice President of Servicing at Drive Financial Services, where they successfully reduced portfolio delinquency by $26M. Following this, they worked as the Sales Director and Partner at Heartsafe America, leading the sales force in selling Automated External Defibrillators and CPR training across the United States.
Mark then transitioned into the medical field and joined Orthofix, where they held various roles such as Territory Manager and Senior Territory Manager. During their time at Orthofix, they promoted biologics, wound care products, and orthopedic hardware to physicians in Dallas/Fort Worth.
In 2014, Mark joined Smith & Nephew as an Extremities Representative III. Mark played a pivotal role in expanding market share for the start-up division by promoting orthopedic and sports medicine products to Foot & Ankle and Hand & Wrist Surgeons. Mark consistently exceeded sales quotas and received recognition for their achievements, including being ranked first among their peers. Mark also served on multiple councils and provided field sales training.
Currently, Mark holds the position of Regional Vice President of Sales at Treace Medical Concepts, Inc. Mark is responsible for growing sales of the Lapiplasty® system in Fort Worth, Texas. Mark's role includes prospecting potential customers, training surgeons, providing sales support, and executing duties assigned by management.
Overall, Mark Gonzales has a successful track record in sales and leadership roles within the medical and financial industries.
Mark Gonzales obtained a Bachelor's degree in Political Science with a Minor in Management from the University of North Texas between the years 1990 and 1994.
This person is not in any offices
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.